This is a follow up to previous notices about our MRO & Software provider (i3screen) discontinuing services to National Drug Screening, Inc (NDS). Your services will not be interrupted.
Effective Aug 1, 2022, your services will continue with no changes with a new provider to whom we are assigning our accounts. This new provider is:
Everything will remain the same. Your usernames, logins, results, random testing records, etc. will all be transferred over to WSI. There will be no change in fee structures.